Four years ago, Covid brought hospital stocks to the limelight. Since then, corporate actions like mergers and takeovers have kept them in ...

Enhertu, a cancer drug by AstraZeneca, was the top-selling new drug in 2024 with sales of nearly Rs 58 crore. Over 3,100 new brands were la...

When valuations across the stock markets are high, one should look for sectors with macro tailwinds. Sectors and stocks with structural tai...

While some make it to the headlines, some don't. Two sectors, healthcare and pharma have been witnessing more mergers and acquisitions than...

In a bullish market many things change and one of them is the relationship between opportunity and challenges. Given the way markets are pa...

After outperforming the market, stocks from the healthcare sector or what is more commonly called hospital sector have gone into consolidat...

One sector which has performed extremely well in the last two years has been hospital space. If one looks at the post listing performance o...

Gilead has partnered with Cognizant for more than three years now to adopt technologies designed to run business operations, new product la...

His innovative work on small molecules, peptides, and natural products offers both diagnostics as well as therapeutics, leading to personal...

The toll-free helpline started by the central government to deal with psycho-social problems faced by people in the wake of Covid-19 crisis...

Boheco is focused on establishing a scale-centric approach towards industrial hemp based products and raw material as well as cannabis-base...

It can be used to control robotic armfor amputee patients or any number of basic processes for paralysed patients from speech to movement o...

Ebola, it seems has been around for over 40 years, and periodically has outbreaks in the poorest parts of Africa. And then what?

The future of our lives, of our work, of our businesses - depends on us gaining a new understanding of the dizzying changes that lie ahead.

Behemoth GE’s global head of medical technology Thomas Gentile speaks of the opportunities for healthcare systems & technologies.

Pharmaceutical firm Suven Life Sciences on Monday said it has received European product patent for its clinical candidate SUVN-502, valid u...

In an effort to popularise the non-invasive and cost-effective complementary ozone therapy, Bombay Hospital has started the therapy for peo...